Predicting pregnancy outcome from the degree of maternal serum α-fetoprotein elevation

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 5, 1996, Pages 327-332

  Cusick, William ^a   Rodis, John F ^b   Vintzileos, Anthony M ^b   Albini, S Mark ^b   McMahon, Megan ^b   Campbell, Winston A ^b  

^a Chicago Center for Human Reproduction   (United States)

^b NONE

Author keywords

Alpha fetoproteins; Infant; Pregnancy outcome; Small for gestational age

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; FEMALE; FETUS; FETUS DEATH; FETUS ECHOGRAPHY; FETUS MALFORMATION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; NEWBORN; PREDICTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 0029984017     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nelson LH, Bensen J, Burton BK: Outcomes in patients with unusually high maternal serum alpha-fetoprotein levels. Am J Obstet Gynecol 1987;157:572-576
2. Milunsky A, Jick SS, Bruell CL, et al: Predictive values, relative risks, and overall benefits of high and low maternal serum α-fetoprotein screening in singleton pregnancies: New epidemiologic data. Am J Obstet Gynecol 1989;161: 291-297
3. Cunningham FG, Gilstrap LC: Maternal serum alpha-fetoprotein screening. N Engl J Med 1991;325:55-57
4. Crandall BF, Robinson L, Grau P: Risks associated with an elevated maternal serum α-fetoprotein level. Am J Obstet Gynecol 1991;165:581-586
5. Robinson L, Grau P, Crandall BF: Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels. Obstet Gynecol. 1989;74:17-20
6. Hamilton MPR, Hossam IA, Whitfield CR: Significance of raised maternal serum α-fetoprotein in singleton pregnancies with normally formed fetuses. Obstet Gynecol 1985; 65:465-470
7. Wenstrom KD, Sipes SL, Williamson RA, et al: Prediction of pregnancy outcome with single versus serial maternal serum α-fetoprotein tests. Am J Obstet Gynecol 1992;167:1529-1533
8. Davis RO, Goldenberg RL, Boots L, et al: Elevated levels of midtrimester maternal serum α-fetoprotein are associated with preterm delivery but not with fetal growth retardation. Am J Obstet Gynecol 1992;167:596-601
9. Cusick W, Vintzileos AM, Rodis JF, et al: The use of second trimester fetal growth curves in predicting intrauterine growth retardation in cases of unexplained maternal serum alpha-fetoprotein elevations. J Matern Fetal Med 1994; 3:195-199
10. Hadlock FP, Harrist RB, Sharman RS, et al: Estimation of fetal weight with the use of head, body, and femur measurements: A prospective study. Am J Obstet Gynecol 1985;151: 333-337
11. Cunningham FG, MacDonald PC, Gant NF: Williams Obstetrics. Norwalk, Connecticut, Appleton and Lange, 1989, p 2
12. Williams RL, Creasy RK, Cunningham GC, et al: Fetal growth and perinatal viability in California. Obstet Gynecol 1982;59:624-632
13. Phillips OP, Simpson JL, Morgan CD, et al: Unexplained elevated maternal serum α-fetoprotein is not predictive of adverse perinatal outcome in an indigent, urban population. Am J Obstet Gynecol 1992;166:978-982
14. Brock DJH, Barron L, Jelen P: Maternal serum alpha-fetoprotein measurements as an early indicator of low birth-weight. Lancet 1977;2:267-268
15. Macri JN, Weiss RR, Libster B, et al: Maternal serum α-fetoprotein and low birth-weight. Lancet 1978;1:660
16. Wald NJ, Cuckle HS, Boreham J: Maternal serum alpha-fetoprotein and birth weight. Br J Obstet Gynaecol 1980;87:860-863
17. Brock DJH, Barron L, Watt M, et al: Maternal plasma α-fetoprotein and low birthweight: A prospective study throughout pregnancy. Br J Obstet Gynaecol 1982;89: 348-351
18. Wald NJ, Cuckle HS, Stirrat GM, et al: Maternal serum alpha-fetoprotein and low birth-weight. Lancet 1977;2: 268-270
19. Smith ML: Raised maternal serum alpha-fetoprotein levels and low birth weight babies. Br J Obstet Gynaecol 1980;87: 1099-1102
20. Purdie DW, Young JL, Guthrie KA, et al: Fetal growth achievement and elevated maternal serum alpha-fetoprotein. Br J Obstet Gynaecol 1983;90:433-436
21. Seppala M, Ruoslahti E: Alpha fetoprotein in maternal serum: A new marker for detection of fetal distress and intrauterine death. Am J Obstet Gynecol 1973;115:48-52
22. Waller DK, Lustig LS, Cunningham GC, et al: Secondtrimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 1991;325: 6-10
23. Burton BK: Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein. Obstet Gynecol 1988;72:709-713
24. Berkeley AS, Killackey MA, Cederqvist LL: Elevated maternal serum α-fetoprotein levels associated with breakdown in fetal-maternal-placental barrier. Am J Obstet Gynecol 1983;146:859-861
25. Katz VL, Bowes WA, Sierkh AE: Maternal floor infarction of the placenta associated with elevated second trimester serum alpha-fetoprotein. Am J Perinatal 1987;4:225-228
26. Perkes EA, Bain RS, Goodman KJ, et al: Second trimester placental changes associated with elevated maternal serum α-fetoprotein. Am J Obstet Gynecol 1982;144:935-938
27. Salafia CM, Silberman L, Herrera NE, et al: Placental pathology at term associated with elevated midtrimester maternal serum α-fetoprotein concentration. Am J Obstet Gynecol 1988;158:1064-1066
28. Hack M, Fanaroff A: Outcomes of extremely low-birth weight infants between 1982 and 1988. N Engl J Med 1989; 321:1642-1647